Showing results (1-10 of 152) with videos related to
Sort By:
Pageof 16
Drug Discovery Today|February 15, 2005
Disease-specific target selection: a critical first step down the right roadAllen D Roses, Daniel K Burns, Stephanie Chissoe, et al.Human Mutation|June 10, 2016
The SSV Evaluation System: A Tool to Prioritize Short Structural Variants for Studies of Possible Regulatory and Causal VariantsRobert Saul, Michael W Lutz, Daniel K Burns, et al.Current Neurology and Neuroscience Reports|April 5, 2016
New Genetic Approaches to AD: Lessons from APOE-TOMM40 PhylogeneticsMichael W Lutz, Donna Crenshaw, Kathleen A Welsh-Bohmer, et al.The EPMA Journal|December 3, 2010
Alzheimer's disease: diagnostics, prognostics and the road to preventionIris Grossman, Michael W Lutz, Donna G Crenshaw, et al.Archives of Neurology|May 12, 2010
An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer diseaseAllen D RosesNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 17, 2008
The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safetyAllen D RosesLife Sciences|March 16, 2002
Pharmacogenetics place in modern medical science and practiceAllen D RosesExpert Opinion on Drug Discovery|March 15, 2013
Genome-wide screening for drug discovery and companion diagnosticsAllen D RosesNature Reviews. Drug Discovery|July 18, 2002
Genome-based pharmacogenetics and the pharmaceutical industryAllen D RosesNature Reviews. Genetics|September 17, 2004
Pharmacogenetics and drug development: the path to safer and more effective drugsAllen D RosesPageof 16